Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein

Abstract

It is projected that in the absence of effective therapy, most individuals infected with human immunodeficiency virus (HIV) will develop acquired immune deficiency syndrome (AIDS) and ultimately succumb to a combination of opportunistic microbial infections, malignancies and direct pathogenic effects of the virus1–3. Anti-viral agents, immunomodulators, and inhibitors of specific HIV functions are being tested as potential treatments to alleviate the high morbidity and mortality4. An alternative therapeutic concept involves the development of cytotoxic agents that are targeted to kill HIV-infected cells. Here we describe the purification and characterization of a recombinant protein produced in Escherichia coli that contains the HIV-binding portion of the human CD4 molecule linked to active regions of Pseudomonas exotoxin A. This hybrid protein displays selective toxicity toward cells expressing the HIV envelope glycoprotein and thus represents a promising novel therapeutic agent for the treatment of AIDS.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Anderson, R. M. & May, R. M. Nature 333, 514–518 (1988).

    Article  ADS  CAS  Google Scholar 

  2. Levy, J. A. Nature 333, 519–522 (1988).

    Article  ADS  CAS  Google Scholar 

  3. Fauci, A. S. Science 239, 617–622 (1988).

    Article  ADS  CAS  Google Scholar 

  4. Mitsuya, H. & Broder, S. Nature 325, 773–778 (1987).

    Article  ADS  CAS  Google Scholar 

  5. Pastan, I., Willingham, M. C. & FitzGerald, D. J. Cell 47, 641–648 (1986).

    Article  CAS  Google Scholar 

  6. Chaudhary, V. K., FitzGerald, D. J., Adhya, S. & Pastan, I. Proc. natn. Acad Sci. U.S.A. 84, 4538–4542 (1987).

    Article  ADS  CAS  Google Scholar 

  7. Lorberboum-Galski, H., FitzGerald, D., Chaudhary, V., Adhya, S. & Pastan, I. Proc natn. Acad. Sci. U.S.A. 85, 1922–1926 (1988).

    Article  ADS  CAS  Google Scholar 

  8. Littman, D. R. A. Rev. Immun. 5, 561–584 (1987).

    Article  CAS  Google Scholar 

  9. Sattentau, Q. J. & Weiss, R. A. Cell 52, 631–633 (1988).

    Article  CAS  Google Scholar 

  10. Smith, D. H. et al. Science 238, 1704–1707 (1987).

    Article  ADS  CAS  Google Scholar 

  11. Fisher, R. A. et al. Nature 331, 76–78 (1988).

    Article  ADS  CAS  Google Scholar 

  12. Hussey, R. E. et al. Nature 331, 78–81 (1988).

    Article  ADS  CAS  Google Scholar 

  13. Deen, K. C. et al. Nature 331, 82–84 (1988).

    Article  ADS  CAS  Google Scholar 

  14. Traunecker, A., Luke, W. & Karjalainen, K. Nature 331, 84–86 (1988).

    Article  ADS  CAS  Google Scholar 

  15. Berger, E. A., Fuerst, T. R. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 85, 2357–2361 (1988).

    Article  ADS  CAS  Google Scholar 

  16. Chakrabarti, S., Robert-Guroff, M., Wong-Staal, F., Gallo, R. C. & Moss, B. Nature 320, 535–537 (1986).

    Article  ADS  CAS  Google Scholar 

  17. Hu, S., Kosowski, S. G. & Dalrymple, J. M. Nature 320, 537–539 (1986).

    Article  ADS  CAS  Google Scholar 

  18. Lifson, J. D. et al. Nature 323, 725–728 (1986).

    Article  ADS  CAS  Google Scholar 

  19. Middlebrook, J. L. & Dorland, R. B. Microbiol. Rev. 48, 199–221 (1984).

  20. Folks, T. M. et al. J. exp. Med. 164, 280–290 (1986).

    Article  CAS  Google Scholar 

  21. Gendelman, H. E. et al. Virology 160, 323–329 (1987).

    Article  CAS  Google Scholar 

  22. Biddison W. E. & Shaw, S. Diagnostic Immun. 1, 112–115 (1983).

    CAS  Google Scholar 

  23. Romain, P. L., Schlossman, S. F. & Reinherz, E. J. Immun. 133, 1093–1100 (1984).

    CAS  PubMed  Google Scholar 

  24. Gay, D. et al. Nature 328, 626–629 (1987).

    Article  ADS  CAS  Google Scholar 

  25. Doyle, C. & Strominger, J. L. Nature 330, 256–259 (1987).

    Article  ADS  CAS  Google Scholar 

  26. Sattentau, et al. AIDS 2, 101–105 (1988).

    Article  CAS  Google Scholar 

  27. Coffin, J. M. Cell 46, 1–4 (1986).

    Article  CAS  Google Scholar 

  28. Studier, F. W. & Moflatt, B. A. J. molec. Biol. 189, 113–130 (1986).

    Article  CAS  Google Scholar 

  29. Chaudhary, V. K., Xu, Y., FitzGerald, D., Adhya, S. & Pastan, I. Proc. natn. Acad. Sci. U.S.A. 85, 2939–2943 (1988).

    Article  ADS  CAS  Google Scholar 

  30. Collier, R. J. & Kandel, J. J. biol. Chem. 246, 1496–1503 (1971).

    CAS  PubMed  Google Scholar 

  31. Laemmli, U. K. Nature 227, 680–685 (1970).

    Article  ADS  CAS  Google Scholar 

  32. Fuerst, T. R., Niles, E. G., Studier, F. W. & Moss, B. Proc. natn. Acad. Sci. U.S.A. 83, 8122–8126 (1986).

    Article  ADS  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chaudhary, V., Mizukami, T., Fuerst, T. et al. Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein. Nature 335, 369–372 (1988). https://doi.org/10.1038/335369a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/335369a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing